Table 2 Meta-regressions exploring the possible moderating factors impacting the area under the curve (AUC).

From: Individualized prediction models in ADHD: a systematic review and meta-regression

Moderating factors

Number of studies

Meta-regression Coefficient

SE

Z value

P

95%CI

(i) Type of validation

External vs Internal validation

62 (58;4)

2.319

–3.79

0.75

0.454

–3.790; 8.474

(ii) Age range

Children&adolescents vs adults

44 (33;11)

–1.612

2.976

–0.54

0.588

–7.444; 4.221

Children&adolescents vs combined/not reported

51 (33;18)

0.482

2.696

0.18

0.858

–4.802; 5.766

Adults vs combined/not reported

29 (11;18)

2.093

3.344

0.63

0.531

–4.460; 8.647

(iii) Type of model

Diagnostic vs prognostic

55 (52;3)

–2.073

5.786

–0.36

0.720

–13.413; 9.268

Diagnostic vs treatment-response

59 (52;7)

1.045

3.538

0.30

0.7677

–5.889; 7.979

Prognostic vs treatment-response

10 (3;7)

3.118

6.514

0.48

0.632

–9.649; 15.885

(iv) Number of predictors

Number of predictors

34

–0.0047

0.003

–1.39

0.166

–0.011; 0.002

(v) Type of predictors

Clinical or service use or sociodemographic vs biomarkers

46 (13; 33)

–1.249

4.337

–0.29

0.773

–9.750; 7.252

Clinical or service use or sociodemographic vs combination

30 (13;17)

–2.749

2.935

–0.94

0.349

–8.502; 3.003

Biomarkers vs combination

50 (33;17)

–0.404

3.786

–0.11

0.915

–7.825; 7.017

Including clinical vs not including clinical

62 (26;36)

–6.540

2.410

–2.72

0.007

–11.264; –1.824

(vi) Modality of predictors

Unimodal vs Multimodal

62 (36;26)

–3.496

1.873

–1.87

0.062

–7.167; 0.174

(vii) Quality assessment

Low risk vs unclear risk

18 (7;11)

3.629

5.058

0.72

0.473

–6.284; 13.542

Low risk vs high risk

51 (7; 44)

5.549

3.910

1.42

0.156

–6.284; 13.542

Unclear risk vs high risk

55 (11; 44)

1.920

3.999

0.48

0.631

–5.918; 9.759